Clinical Trial Update: Renal Impairment in Type 2 Diabetic Subjects [Phase 1]

View source ↗

Summary

This Phase 1 trial update from AstraZeneca investigates renal impairment in subjects with Type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: AstraZeneca | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED